{
    "accession": "ENCBS568BOG",
    "age": "4",
    "age_units": "year",
    "applied_modifications": [
        {
            "category": "insertion",
            "introduced_tags": [
                {
                    "location": "C-terminal",
                    "name": "eGFP"
                }
            ],
            "method": "CRISPR",
            "modified_site_by_target_id": "PATZ1",
            "purpose": "tagging"
        }
    ],
    "biosample_term_id": "EFO:0003072",
    "biosample_term_name": "SK-N-SH",
    "biosample_type": "cell line",
    "characterizations": [
        {
            "references": []
        }
    ],
    "dbxrefs": [],
    "description": "",
    "documents": [],
    "donor": "ENCDO000ABD",
    "health_status": "Metastatic neuroblastoma from bone marrow",
    "lab": "Michael Snyder, Stanford",
    "life_stage": "child",
    "organism": "Homo sapiens",
    "references": [],
    "sex": "female",
    "source": "ATCC",
    "summary": "Homo sapiens SK-N-SH cell line genetically modified (insertion) using CRISPR targeting PATZ1 treated with 6 \u03bcM all-trans-retinoic acid for 48 hours",
    "treatments": [
        {
            "dbxrefs": [],
            "duration": 48,
            "duration_units": "hour",
            "treatment_term_id": "CHEBI:15367",
            "treatment_term_name": "all-trans-retinoic acid",
            "treatment_type": "chemical"
        }
    ]
}